Source comparison
Best ARA-290 Dosage for Tissue Repair: Protocol Comparison
| Protocol Type | Dosage | Frequency | Duration | Injury Phase | Bottom Line ||—|—|—|—|—|| Acute Soft Tissue Injury | 6–8mg SC | 3× weekly | 4–6 weeks | Days 0–14 (inflammatory + early proliferative) | Front-loaded dosing during peak inflammation yields fastes
This comparison does not assign a generated winner or score.
- | Protocol Type | Dosage | Frequency | Duration | Injury Phase | Bottom Line ||—|—|—|—|—|| Acute Soft Tissue Injury | 6–8mg SC | 3× weekly | 4–6 weeks | Days 0–14 (inflammatory + early proliferative) | Front-loaded dosing during peak inflammation yields fastest functional recovery; taper after week 4 || Chronic Neuropathic Pain | 4–6mg SC | 3× weekly | 8–12 weeks | Ongoing low-grade inflammation | Sustained moderate dosing suppresses persistent cytokine signaling; maintenance at 2–4mg twice weekly post-acute || Surgical Wound Healing | 4mg SC | 3× weekly | 6–8 weeks | Post-operative days 3–14 (proliferative phase) | Lower doses sufficient once surgical inflammation resolves; focus on angiogenic support during collagen deposition || Severe Nerve Injury | 8–10mg SC | 3× weekly | 8–10 weeks | Days 0–21 (Wallerian degeneration + early regeneration) | Higher doses required to overcome intense pro-inflammatory environment in axonal injury; taper once sensory recovery plateaus || Maintenance/